Herborium Group Inc (HBRM)

[Tobin F]

In reading a recent filing, I pulled out this section:

"Changing FDA perspectives with respect to botanical drugs now encourage the performance of Phase I and Phase II clinical studies. Herborium has developed preliminary collaborative relationships with proactive medical institutions (e.g. Johns Hopkins University) in the USA and number of TCM research institutions in the USA, UK and Asia. These alliances will facilitate product development and clinical studies to be performed following financing. Successful completion of these studies will allow advertising claims of “Clinically Proven” which will greatly facilitate marketing efforts and possibly also include partial reimburse-ment opportunities for selected products (Several HMOs in the USA already re-imburse preventive and alternative therapies). In selected clinically and market justified cases, Herborium may pursue further clinical testing to develop botanical drugs rather than botanical therapeutics® and take advantage of both the pharma-ceuticals market and licensing opportunities."

"have developed relationships"..this takes time. This isn't a flipper's dream stock. This is long haul reward stock.